Global Covid-19 Vaccine Competitive Landscape Professional Research Report 2024
Research Summary
COVID-19 vaccines are medical products developed to provide immunity against the SARS-CoV-2 virus, which causes COVID-19. These vaccines aim to trigger an immune response in the body without causing the disease itself. They contain a weakened or inactivated form of the virus, specific viral proteins, or genetic material that instructs the body's cells to produce viral proteins. Once administered, the immune system recognizes these viral components as foreign and mounts an immune response by producing antibodies and memory cells. In the event of a future infection, the immune system can quickly recognize and neutralize the virus, preventing severe illness and reducing the risk of transmission to others. COVID-19 vaccines have been a critical tool in combating the pandemic and are deployed through mass vaccination campaigns worldwide. Rigorous testing and regulatory approval processes ensure their safety and efficacy, and ongoing research and monitoring continue to provide valuable data on vaccine effectiveness, duration of immunity, and potential variants. Vaccination, along with other preventive measures, such as mask-wearing and social distancing, plays a crucial role in controlling the spread of COVID-19 and bringing an end to the global health crisis.
According to DIResearch's in-depth investigation and research, the global Covid-19 Vaccine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Covid-19 Vaccine include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson&Johnson, Heat Biologics, Sanofi etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Covid-19 Vaccine. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Covid-19 Vaccine market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Covid-19 Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Covid-19 Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Covid-19 Vaccine Include:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson&Johnson
Heat Biologics
Sanofi
Covid-19 Vaccine Product Segment Include:
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Covid-19 Vaccine Product Application Include:
Adults
Children
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Covid-19 Vaccine Industry PESTEL Analysis
Chapter 3: Global Covid-19 Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Covid-19 Vaccine Major Regional Market Size and Forecast Analysis
Chapter 5: Global Covid-19 Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Covid-19 Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Covid-19 Vaccine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources